Pharma Attacked For “Playing The System” Of EU Pediatric Rewards
Executive Summary
As a public consultation on the impact of the EU Paediatric Regulation comes to an end, the French drug bulletin Prescrire has attacked pharma firms for taking advantage of the rewards and incentives provided in the regulation and paying only lip service to the need for new medicines for children.